Toward neurotrophin-based therapeutics

Am J Psychiatry. 2011 Feb;168(2):114-6. doi: 10.1176/appi.ajp.2010.10111677.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Amygdala / drug effects
  • Amygdala / physiopathology
  • Animals
  • Brain-Derived Neurotrophic Factor / physiology*
  • Conditioning, Classical / drug effects
  • Conditioning, Classical / physiology
  • Disease Models, Animal
  • Extinction, Psychological / drug effects
  • Extinction, Psychological / physiology
  • Flavones / pharmacology*
  • Flavones / therapeutic use*
  • Genetic Therapy
  • Humans
  • Learning / drug effects
  • Learning / physiology
  • Memory / drug effects
  • Memory / physiology
  • Mental Disorders / drug therapy*
  • Mental Disorders / genetics
  • Mental Disorders / physiopathology*
  • Mice
  • Neurodegenerative Diseases / drug therapy*
  • Neurodegenerative Diseases / genetics
  • Neurodegenerative Diseases / physiopathology*
  • Neurons / drug effects
  • Neurons / physiology
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use*
  • Receptor, trkB / agonists*
  • Receptor, trkB / genetics
  • Receptor, trkB / physiology
  • Signal Transduction / drug effects*
  • Signal Transduction / genetics

Substances

  • 6,7-dihydroxyflavone
  • Brain-Derived Neurotrophic Factor
  • Flavones
  • Neuroprotective Agents
  • Receptor, trkB